Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.

Patients with ITP admitted for AMI had a similar in-hospital mortality risk, but a significantly higher risk of bleeding complications and a longer LOS compared to those without ITP. Further studies are needed to assess optimal management strategies of AMI that minimize complications while improving outcomes in this population.